Hjem
Anders Engelands bilde
Foto:
Privat
  • E-postAnders.Engeland@uib.no
  • Telefon+47 55 58 61 27+47 970 18 094
  • Besøksadresse
    Alrek helseklynge, blokk D, Årstadveien 17
  • Postadresse
    Postboks 7804
    5020 Bergen

Legemiddelepidemiologi

Kreftepidemiologi

Livsstilsepidemiologi

 

 

  • Veileder medisinerstudenter (særoppgave) og PhD studenter
  • Vis forfatter(e) 2021. The Norwegian Society for Pharmacoepidemiology. Norsk Epidemiologi. 5-6.
  • Vis forfatter(e) 2021. Prescribed drugs in 27 000 individuals after diagnosis of colorectal cancer: A population-based cohort study. Pharmacoepidemiology and Drug Safety. 1037-1048.
  • Vis forfatter(e) 2021. Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project. International Journal of Cancer. 1-9.
  • Vis forfatter(e) 2021. Male to female ratios in autism spectrum disorders by age, intellectual disability and attention-deficit/hyperactivity disorder. Acta Psychiatrica Scandinavica. 1-12.
  • Vis forfatter(e) 2020. Validation of assisted reproductive technology in the Medical Birth Registry of Norway versus the Norwegian Prescription Database. Epidemiology. 681-686.
  • Vis forfatter(e) 2020. Urinary incontinence associated with anxiety and depression: the impact of psychotropic drugs in a cross-sectional study from the Norwegian HUNT study. BMC Psychiatry. 1-10.
  • Vis forfatter(e) 2020. Sex differences in parent–offspring recurrence of attention-deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry. 1-9.
  • Vis forfatter(e) 2020. Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study. British Journal of Cancer. 161-166.
  • Vis forfatter(e) 2020. Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study. The Lancet Diabetes and Endocrinology. 94-105.
  • Vis forfatter(e) 2020. Incidence of Malformations After Early Pregnancy Exposure to Modafinil in Sweden and Norway. Journal of the American Medical Association (JAMA). 895-896.
  • Vis forfatter(e) 2020. Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults. The BMJ. 14 sider.
  • Vis forfatter(e) 2020. Antipsychotic drug use in pregnancy: A multinational study from ten countries. Schizophrenia Research. 106-115.
  • Vis forfatter(e) 2019. The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. International Journal of Epidemiology. 93-104.
  • Vis forfatter(e) 2019. Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway. Pharmacology Research & Perspectives. 1-10.
  • Vis forfatter(e) 2019. Patterns of psychiatric comorbidity and genetic correlations provide new insights into differences between attention-deficit/hyperactivity disorder and autism spectrum disorder. Biological Psychiatry. 46 sider.
  • Vis forfatter(e) 2019. Parent-offspring recurrence of attention-deficit/hyperactivity disorder.
  • Vis forfatter(e) 2019. Parent-offspring recurrence of ADHD.
  • Vis forfatter(e) 2019. Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals. International Journal of Cancer. 58-67.
  • Vis forfatter(e) 2019. Epilepsy and autoimmune diseases: Comorbidity in a national patient cohort. Seizure. 89-95.
  • Vis forfatter(e) 2019. BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study. International Journal of Epidemiology. 1872-1885.
  • Vis forfatter(e) 2019. Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study. International Journal of Cancer. 1-10.
  • Vis forfatter(e) 2018. Urate and the risk of Parkinson's disease in men and women. Parkinsonism & Related Disorders. 76-82.
  • Vis forfatter(e) 2018. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiology and Drug Safety. 995-1004.
  • Vis forfatter(e) 2018. Psychiatric comorbidity and genetic correlations provide new insights into differences between ADHD and autism .
  • Vis forfatter(e) 2018. Psychiatric comorbidity and genetic correlations provide new insights into differences between ADHD and autism .
  • Vis forfatter(e) 2018. Psychiatric comorbidities in adults with ADHD and/or autism: Can patterns of comorbidities together with genetics add knowledge on etiologic relations? .
  • Vis forfatter(e) 2018. Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women. International Journal of Cancer. 1858-1867.
  • Vis forfatter(e) 2018. Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study. International Journal of Cancer. 1904-1913.
  • Vis forfatter(e) 2018. Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death. Journal of the American Medical Association (JAMA). 2333-2335.
  • Vis forfatter(e) 2018. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Addiction. 1286-1294.
  • Vis forfatter(e) 2018. Diabetes is associated with decreased migraine risk: A nationwide cohort study. Cephalalgia. 1759-1764.
  • Vis forfatter(e) 2018. Beta-blocker use in pregnancy and the risk of congenital malformations: An international cohort study. Annals of Internal Medicine. 665-673.
  • Vis forfatter(e) 2017. beta(2)-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson's disease. Science. 891-897.
  • Vis forfatter(e) 2017. The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures. European Journal of Clinical Pharmacology. 513-520.
  • Vis forfatter(e) 2017. Psychiatric comorbidities in male and female adults with ADHD.
  • Vis forfatter(e) 2017. Preterm births and use of medication in early adulthood: a population-based registry study. Pharmacoepidemiology and Drug Safety. 742-751.
  • Vis forfatter(e) 2017. OMT or drug abuse during pregnancy - does it affect the offspring? Results from Nationwide registry studies in the Czech Republic and Norway.
  • Vis forfatter(e) 2017. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. The BMJ. 8 sider.
  • Vis forfatter(e) 2017. Neonatal Outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
  • Vis forfatter(e) 2017. Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatrica Scandinavica. 176-186.
  • Vis forfatter(e) 2017. Gender Differences in Psychiatric Comorbidity: A Population-based Study of 40,000 Adults with Attention-Deficit/Hyperactivity Disorder.
  • Vis forfatter(e) 2017. Correction to: Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. European Child and Adolescent Psychiatry. 1-1.
  • Vis forfatter(e) 2017. Condition of newborns of women received OMT and opiates during pregnancy: comparison of Czech and Norwegian cohorts.
  • Vis forfatter(e) 2017. Cohort Profile Update: The Janus Serum Bank Cohort in Norway. International Journal of Epidemiology. 1101-1102f.
  • Vis forfatter(e) 2017. Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biological Psychiatry. 452-459.
  • Vis forfatter(e) 2017. Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. European Child and Adolescent Psychiatry. 1-13.
  • Vis forfatter(e) 2017. Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: A cohort study from the international pregnancy safety study consortium. JAMA psychiatry. 167-175.
  • Vis forfatter(e) 2016. Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: Analysis of linked databases in Wales, Norway and Funen, Denmark. PLOS ONE. 26 sider.
  • Vis forfatter(e) 2016. Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy – a cohort linkage study. BJOG: An International Journal of Obstetrics and Gynaecology. 1609-1618.
  • Vis forfatter(e) 2016. Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case–control study. British Journal of Cancer. 1416-1420.
  • Vis forfatter(e) 2016. Psychotropic Drug Exposure and Hip Fractures.
  • Vis forfatter(e) 2016. Prescribing of antidiabetic medicines before, during and after pregnancy: A study in seven European regions. PLOS ONE. 17 sider.
  • Vis forfatter(e) 2016. Pre-eclampsia and childhood asthma. European Respiratory Journal. 1622-1630.
  • Vis forfatter(e) 2016. Educational attainment among long-term survivors of cancer in childhood and adolescence: a Norwegian population-based cohort study. Journal of cancer survivorship. 87-95.
  • Vis forfatter(e) 2016. Does the choice of antiepileptic drug affect survival in glioblastoma patients? Journal of Neuro-Oncology. 461-469.
  • Vis forfatter(e) 2016. Asthma medication prescribing before, during and after pregnancy: a study in seven European regions. BMJ Open. 13 sider.
  • Vis forfatter(e) 2016. Antipsychotic drugs and risk of hip fracture among people older than 60 years in Norway. Journal of The American Geriatrics Society. 1203-1209.
  • Vis forfatter(e) 2015. Use of antidepressants and association with elective termination of pregnancy: population based case-control study. BJOG: An International Journal of Obstetrics and Gynaecology. 1618-1624.
  • Vis forfatter(e) 2015. Social inequalities and smoking-associated breast cancer - Results from a prospective cohort study. Preventive Medicine. 125-129.
  • Vis forfatter(e) 2015. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: Population based cohort study and sibling design. The BMJ.
  • Vis forfatter(e) 2015. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study. BMC Geriatrics. 1-10.
  • Vis forfatter(e) 2015. Preeclampsia in pregnancy and later use of antihypertensive drugs. European Journal of Epidemiology (EJE). 501-508.
  • Vis forfatter(e) 2015. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. International Journal of Epidemiology. 1353-1363.
  • Vis forfatter(e) 2015. Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions. Pharmacoepidemiology and Drug Safety. 1144-1154.
  • Vis forfatter(e) 2014. Total drug treatment and comorbidity in myasthenia gravis: A population-based cohort study. European Journal of Neurology. 948-955.
  • Vis forfatter(e) 2014. The Association between Lifetime Smoking Exposure and Breast Cancer Mortality – Results from a Norwegian Cohort. Cancer Medicine. 1448-1457.
  • Vis forfatter(e) 2014. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. European Journal of Clinical Pharmacology. 873-880.
  • Vis forfatter(e) 2014. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a 6-year follow-up study based on nationwide registries.
  • Vis forfatter(e) 2014. Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations. Epidemiology. 823-828.
  • Vis forfatter(e) 2014. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes and Control. 151-159.
  • Vis forfatter(e) 2014. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurologica Scandinavica. 26-31.
  • Vis forfatter(e) 2014. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: A prospective study of 580 000 subjects within the Me-Can project. BMC Cancer. 12 sider.
  • Vis forfatter(e) 2014. Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation. Acta Obstetricia et Gynecologica Scandinavica. 647-653.
  • Vis forfatter(e) 2014. Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study. European Journal of Clinical Pharmacology. 1367-1374.
  • Vis forfatter(e) 2014. Associations between hip fractures & psychotropic drugs - a Nationwide prospective cohort study.
  • Vis forfatter(e) 2014. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLOS ONE.
  • Vis forfatter(e) 2013. Total serum cholesterol and cancer incidence in the Metabolic Syndrome and Cancer Project (Me-Can). PLOS ONE. 8 sider.
  • Vis forfatter(e) 2013. Smoking duration before first childbirth: an emerging risk factor for breast cancer? Results from 302,865 Norwegian women. Cancer Causes and Control. 1347-1356.
  • Vis forfatter(e) 2013. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. Journal of the American Medical Association (JAMA). 48-54.
  • Vis forfatter(e) 2013. Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination. New England Journal of Medicine. 333-340.
  • Vis forfatter(e) 2013. Risk of Fetal Death After Pandemic Influenza Virus Infection or Vaccination EDITORIAL COMMENT. Obstetrical and Gynecological Survey. 348-349.
  • Vis forfatter(e) 2013. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes and Control. 107-116.
  • Vis forfatter(e) 2013. Prescription drug use among pregnant women in opioid Maintenance Treatment. Addiction. 367-376.
  • Vis forfatter(e) 2013. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes and Control. 151-159.
  • Vis forfatter(e) 2013. Metabolic Factors Associated with Risk of Renal Cell Carcinoma. PLOS ONE.
  • Vis forfatter(e) 2013. Increased uptake of social security benefits among long-term survivors of cancer in childhood, adolescence and young adulthood: a Norwegian population-based cohort study. British Journal of Cancer. 1525-1533.
  • Vis forfatter(e) 2013. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry. Age and Ageing. 514-520.
  • Vis forfatter(e) 2013. Fetal growth and childhood cancer: A population-based study. Pediatrics. E1265-E1275.
  • Vis forfatter(e) 2013. Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340,000 pregnancies using Norwegian population-based databases. British Journal of Clinical Pharmacology. 1134-1141.
  • Vis forfatter(e) 2012. The 2009 Influenza Pandemic, Vaccination during Pregnancy and Fetal Death: A National Registry-Based Study in Norway. Pharmacoepidemiology and Drug Safety. 382-382.
  • Vis forfatter(e) 2012. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ. British Medical Journal. 9 sider.
  • Vis forfatter(e) 2012. Prospective study on metabolic factors and risk of prostate cancer. Cancer. 6199-6206.
  • Vis forfatter(e) 2012. Prescription Drug Use among Pregnant Women in Opioid Maintenance Treatment. Pharmacoepidemiology and Drug Safety. 388-388.
  • Vis forfatter(e) 2012. Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs. Pharmacoepidemiology and Drug Safety. 929-936.
  • Vis forfatter(e) 2012. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathers. Scandinavian Journal of Rheumatology. 196-201.
  • Vis forfatter(e) 2012. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can). British Journal of Dermatology. 59-67.
  • Vis forfatter(e) 2012. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. International Journal of Cancer. 193-200.
  • Vis forfatter(e) 2012. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Gynecologic Oncology. 330-335.
  • Vis forfatter(e) 2012. Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Annals of Hematology. 1519-1531.
  • Vis forfatter(e) 2012. Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards. Scandinavian Journal of Primary Health Care. 169-175.
  • Vis forfatter(e) 2012. Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential. Clinical Pharmacology and Therapeutics. 438-441.
  • Vis forfatter(e) 2012. Co-prescription of medication for bipolar disorder and diabetes mellitus: A nationwide population-based study. BMC Medicine. 6 sider.
  • Vis forfatter(e) 2012. Blood pressure and risk of cancer incidence and mortality in the Metabolic syndrome and cancer project. Hypertension. 802-810.
  • Vis forfatter(e) 2012. Blood pressure and other metabolic syndrome factors and risk of brain tumor in the large population-based Me-Can cohort study. Journal of Hypertension. 290-296.
  • Vis forfatter(e) 2012. An increased risk of motor vehicle accidents after prescription of methadone. Addiction. 967-972.
  • Vis forfatter(e) 2011. Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study. European Journal of Clinical Pharmacology. 953-960.
  • Vis forfatter(e) 2011. Use of Legally Prescribed Opioid Analgesics in Pregnant Women and Risk of Spontaneous Preterm Birth. A Population Based Cohort Study, Norway 2004-2008. Pharmacoepidemiology and Drug Safety. S75-S75.
  • Vis forfatter(e) 2011. USE OF PRESCRIBED DRUGS FOR THE NERVOUS SYSTEM AMONG WOMEN IN OPIOID MAINTENANCE TREATMENT BEFORE AND DURING PREGNANCY IN NORWAY, 2004-2008. Drug and Alcohol Review. 57-57.
  • Vis forfatter(e) 2011. Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes and Control. 291-299.
  • Vis forfatter(e) 2011. Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. European Journal of Epidemiology (EJE). 157-163.
  • Vis forfatter(e) 2011. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). International Journal of Cancer. 1890-1898.
  • Vis forfatter(e) 2011. Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can). Annals of Oncology. 1339-1345.
  • Vis forfatter(e) 2011. Metabolic risk factors and ovarian cancer in the Metabolic syndrome and cancer project. International Journal of Epidemiology. 1667-1677.
  • Vis forfatter(e) 2011. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes and Control. 743-751.
  • Vis forfatter(e) 2011. Metabolic Factors and the Risk of Colorectal Cancer in 580,000 Men and Women in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer. 2398-2407.
  • Vis forfatter(e) 2011. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiology and Drug Safety. 243-248.
  • Vis forfatter(e) 2011. An increased risk of road traffic accidents after prescriptions of methadone. Addiction.
  • Vis forfatter(e) 2010. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. European Journal of Neurology. 1445-1450.
  • Vis forfatter(e) 2010. Metabolic syndrome and endometrial carcinoma. American Journal of Epidemiology. 892-902.
  • Vis forfatter(e) 2010. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiology, Biomarkers and Prevention. 1737-1745.
  • Vis forfatter(e) 2010. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiology, Biomarkers and Prevention. 2307-2317.
  • Vis forfatter(e) 2010. Does Pregabalin (Lyrica (R)) help patients reduce their use of Benzodiazepines? A comparison with gabapentin using the norwegian prescription database. Basic & Clinical Pharmacology & Toxicology. 883-886.
  • Vis forfatter(e) 2010. Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). International Journal of Epidemiology. 660-667.
  • Vis forfatter(e) 2009. Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstetricia et Gynecologica Scandinavica. 1083-1089.
  • Vis forfatter(e) 2009. Use of opioids in mothers and fathers before and during pregnancy-2004-2006. Pharmacoepidemiology and Drug Safety. S71-S72.
  • Vis forfatter(e) 2009. Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study. Pharmacoepidemiology and Drug Safety. 737-742.
  • Vis forfatter(e) 2009. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007-A prescription database study. Journal of Affective Disorders. 208-211.
  • Vis forfatter(e) 2009. The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol. Clinical Pharmacology and Therapeutics. 596-599.
  • Vis forfatter(e) 2009. Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. European Journal of Clinical Pharmacology. 295-301.
  • Vis forfatter(e) 2009. Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study. Diabetic Medicine. 404-408.
  • Vis forfatter(e) 2009. Myasthenia gravis requiring drug treatment in a national population cohort. European Journal of Neurology. S207.
  • Vis forfatter(e) 2009. Fetal down syndrome and the risk of maternal breast cancer. Epidemiology. 584-589.
  • Vis forfatter(e) 2009. An increased risk of road traffic accidents after prescriptions of lithium or valproate? Pharmacoepidemiology and Drug Safety. 492-496.
  • Vis forfatter(e) 2008. Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie. Norsk Epidemiologi. 159-165.
  • Vis forfatter(e) 2008. Use of antirheumatic drugs in mothers and fathers before and during pregnancy, 2004-2006. Pharmacoepidemiology and Drug Safety. S158.
  • Vis forfatter(e) 2008. Use of antirheumatic drugs in mothers and fathers before and during pregnancy. Annals of the Rheumatic Diseases. 581-581.
  • Vis forfatter(e) 2008. The use of lithium, valproate or lamotrigine as mood stabilizers in children and adolescents in Norway 2004-2007. Pharmacoepidemiology and Drug Safety. S90-S91.
  • Vis forfatter(e) 2008. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Medicine. 818-822.
  • Vis forfatter(e) 2008. Repeated dispensing of codeine is associated with high consumption of benzodiazepines. Norsk Epidemiologi. 185-190.
  • Vis forfatter(e) 2008. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006. British Journal of Clinical Pharmacology. 653-660.
  • Vis forfatter(e) 2008. Patients treated with insulin or oral blood glucose lowering drugs and risk of road traffic accidents: A registry-based cohort study. Pharmacoepidemiology and Drug Safety. S190.
  • Vis forfatter(e) 2008. No increase in risk of road traffic accidents after prescriptions of mood stabilizers. Pharmacoepidemiology and Drug Safety. S19-S20.
  • Vis forfatter(e) 2008. Minor increase in risk of road traffic accidents after prescriptions of antidepressants: A study of population registry data in Norway. Journal of Clinical Psychiatry. 1099-1103.
  • Vis forfatter(e) 2008. Cohort Profile: Cohort of Norway (CONOR). International Journal of Epidemiology. 481-485.
  • Vis forfatter(e) 2008. Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway. Scandinavian Journal of Medicine & Science in Sports. 309-317.
  • Vis forfatter(e) 2008. Cancer risk in children with birth defects and in their families: A population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiology, Biomarkers and Prevention. 500-506.
  • Vis forfatter(e) 2008. Body mass index in adolescence in relation to cause-specific mortality: A follow-up of 230,000 Norwegian adolescents. American Journal of Epidemiology. 30-37.
  • Vis forfatter(e) 2008. Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study. British Journal of Cancer. 1165-1169.
  • Vis forfatter(e) 2007. Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie.
  • Vis forfatter(e) 2007. Use of stimulants for ADHD among children and adolescents in Norway: - a population based study 2004-2006.
  • Vis forfatter(e) 2007. Traffic accident risks associated with the prescription of medicinal drugs: A registry-based cohort study. Pharmacoepidemiology and Drug Safety. S12.
  • Vis forfatter(e) 2007. Traffic accident risk associated with the prescription of hypnotic drugs: a registry-based cohort study.
  • Vis forfatter(e) 2007. The risk of traffic accidents after prescriptions of carisoprodol. Accident Analysis and Prevention. 1050-1055.
  • Vis forfatter(e) 2007. Risk of road traffic accidents associated with the prescription of drugs: A registry-based cohort study. Annals of Epidemiology. 597-602.
  • Vis forfatter(e) 2007. Psychostimulant use among children and adolescents with ADHD in Norway: a population based study 2004-2006.
  • Vis forfatter(e) 2007. Psychostimulant use among children and adolescents with ADHD in Norway: A population based study 2004-2006. Pharmacoepidemiology and Drug Safety.
  • Vis forfatter(e) 2007. Prescription drug use before, during and after pregnancy among 50,000 women in Norway in 2004-2005. Pharmacoepidemiology and Drug Safety.
  • Vis forfatter(e) 2007. Prescription drug use before, during and after pregnancy among 50 000 women in Norway in 2004-2005.
  • Vis forfatter(e) 2007. Prescription drug use before, during and after pregnancy among 50 000 women in Norway in 2004-2005.
  • Vis forfatter(e) 2007. Medikamentbruk i forbindelse med svangerskap.
  • Vis forfatter(e) 2007. Medikamentbruk i forbindelse med svangerskap.
  • Vis forfatter(e) 2007. Height and body mass index and risk of lymphohematopoietic malignancies in two million norwegian men and women. American Journal of Epidemiology. 44-52.
  • Vis forfatter(e) 2007. Carisoprodol use and abuse in Norway. A pharmacoepidemiological study. British Journal of Clinical Pharmacology. 210-218.
  • Vis forfatter(e) 2007. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. International Journal of Cancer. 378-383.
  • Vis forfatter(e) 2007. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study. BMC Clinical Pharmacology.
  • Vis forfatter(e) 2007. Antidepressiver hos barn og ungdom - førte advarsler til færre forskrivninger? Tidsskrift for Den norske legeforening. 2653-2655.
  • Vis forfatter(e) 2007. Age- and gender-specific antibacterial prescribing in Norway. Journal of Antimicrobial Chemotherapy. 971-976.
  • Vis forfatter(e) 2006. The prevalence and incidence of drug treated bipolar disorder in the adult(20-65 years) as seen in the Norwegian prescription database.
  • Vis forfatter(e) 2006. The prevalence and incidence of drug treated bipolar disorder in the adult(20-65 years) as seen in the Norwegian prescription database.
  • Vis forfatter(e) 2006. The pharmacoepidemiology of carisoprodol misuse and abuse.
  • Vis forfatter(e) 2006. The pharmacoepidemiology of Carisoprodol misuse and abuse. Pharmacoepidemiology and Drug Safety. S112-S113.
  • Vis forfatter(e) 2006. The impact of medicinal authority's warnings on the prescribing of SSRI antidepressants to children and adolescents in Norway. Pharmacoepidemiology and Drug Safety. S211-S211.
  • Vis forfatter(e) 2006. The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. Cancer Causes and Control. 983-987.
  • Vis forfatter(e) 2006. The impact of body mass index on later total hip arthroplasty for primary osteoarthritis - A cohort study in 1.2 million persons. Arthritis and Rheumatism. 802-807.
  • Vis forfatter(e) 2006. The Impact of Medicinal Authority's Warnings on the Prescribing of SSRI Antidepressants to Children and Adolescents in Norway.
  • Vis forfatter(e) 2006. Hvor mange og hvem behandles medikamentelt for diabetes mellitus? Tidsskrift for Den norske legeforening. 768-770.
  • Vis forfatter(e) 2006. How many and who are receiving medication for treatment of diabetes mellitus in Norway? Pharmacoepidemiology and Drug Safety. S162-S162.
  • Vis forfatter(e) 2006. How many and who are receiving medication for treatment of diabetes mellitus in Norway?
  • Vis forfatter(e) 2006. Endringer i salg og bruk av flunitrazepam etter 1999. Tidsskrift for Den norske legeforening. 589-590.
  • Vis forfatter(e) 2006. Comparison of statin use in three Norwegian counties in 2004- an individualised prescription database study.
  • Vis forfatter(e) 2006. Comparison of statin use in three Norwegian counties in 2004 - An individualised prescription database study. Pharmacoepidemiology and Drug Safety. S256-S256.
  • Vis forfatter(e) 2006. Body size and thyroid cancer in two million Norwegian men and women. British Journal of Cancer. 366-370.
  • Vis forfatter(e) 2006. Age and sex specific antibacterial prescribing in Norway. Pharmacoepidemiology and Drug Safety. S69-S69.
  • Vis forfatter(e) 2005. The Norwegian prescription database(NorPD)-a new register for pharmacoepidemiologic research covering a whole nation.
  • Vis forfatter(e) 2005. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes and Control. 987-996.
  • Vis forfatter(e) 2005. Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. British Journal of Cancer. 807-810.
  • Vis forfatter(e) 2005. Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. British Journal of Cancer. 807-810.
  • Vis forfatter(e) 2005. Do variations in sales of lipid-lowering drugs reflect true prevalences of use?A prescription database study of lipid-lowering drugs in regions with high (Hedmark), average (Oppland) and low (Troms) total sales.
  • Vis forfatter(e) 2004. Relation of Height and Body Mass Index to Renal Cell Carcinoma in Two Million Norwegian Men and Women. American Journal of Epidemiology. 1168-1176.
  • Vis forfatter(e) 2004. Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology. 79-85.
  • Vis forfatter(e) 2004. Body mass index in relation to adult asthma among 135,000 Norwegian men and women. American Journal of Epidemiology. 169-976.
  • Vis forfatter(e) 2003. Height, body mass index and prostate cancer: a follow-up of 950 000 Norwegian men. British Journal of Cancer. 1237-1242.
  • Vis forfatter(e) 2003. Height, body mass index and ovarian cancer: a follow-up of 1.1 million Norwegian women. Journal of the National Cancer Institute. 1244-1248.
  • Vis forfatter(e) 2003. Er det forskjeller i forekomst av underarmsbrudd mellom by og land i Norge? Data fra CONOR.
  • Vis forfatter(e) 2003. CONOR (Cohort NORway) - en oversikt over en unik forskningdata. Norsk Epidemiologi. 72-77.
  • Vis forfatter(e) 2003. Body mass index in adolescence in relation to total mortality: 32 year follow-up 227, Norwegian and girls. American Journal of Epidemiology. 517-523.
  • Vis forfatter(e) 2003. A height and body mass index in relation to total mortality. Epidemiology. 293-299.
  • Vis forfatter(e) 2002. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. British Journal of Cancer. 61-64.
  • Vis forfatter(e) 2002. Effects of first aid training in junior high schools. Injury control and safety promotion. 99-106.
  • Vis forfatter(e) 2002. Bruk av p-piller og risiko for kreft. Tidsskrift for Den norske legeforening. 1788-1790.

Se fullstendig oversikt over publikasjoner i CRIStin.

  • Medikamentbruk i forbindelse med svangerskap

  • Legemiddelbruk og hoftebrudd
  • Metabolsk syndrom og kreft

  • Forhold under graviditet og fødselskarakteristika i relasjon til kreft blant barn og ungdom
  • Kreftrisiko i familier med barn med medfødte misdannelser

 

Cand. Scient. (matematisk statistikk)

Dr. philos. i kreftepidemiologi

Forskergrupper